- Home
- OABI vs LGI Comparison
OABI vs LGI Comparison
Compare OABI & LGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- LGI
- Stock Information
- Founded
- OABI 2012
- LGI 2004
- Country
- OABI United States
- LGI United States
- Employees
- OABI N/A
- LGI N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- LGI
- Sector
- OABI Health Care
- LGI
- Exchange
- OABI Nasdaq
- LGI Nasdaq
- Market Cap
- OABI 185.9M
- LGI 210.5M
- IPO Year
- OABI N/A
- LGI N/A
- Fundamental
- Price
- OABI $1.38
- LGI $16.21
- Analyst Decision
- OABI Strong Buy
- LGI
- Analyst Count
- OABI 3
- LGI 0
- Target Price
- OABI $7.00
- LGI N/A
- AVG Volume (30 Days)
- OABI 953.8K
- LGI 41.1K
- Earning Date
- OABI 05-08-2025
- LGI 01-01-0001
- Dividend Yield
- OABI N/A
- LGI 7.10%
- EPS Growth
- OABI N/A
- LGI N/A
- EPS
- OABI N/A
- LGI N/A
- Revenue
- OABI $26,744,000.00
- LGI N/A
- Revenue This Year
- OABI N/A
- LGI N/A
- Revenue Next Year
- OABI $40.06
- LGI N/A
- P/E Ratio
- OABI N/A
- LGI N/A
- Revenue Growth
- OABI 27.07
- LGI N/A
- 52 Week Low
- OABI $1.22
- LGI $12.66
- 52 Week High
- OABI $4.96
- LGI $16.68
- Technical
- Relative Strength Index (RSI)
- OABI 39.15
- LGI 60.25
- Support Level
- OABI $1.22
- LGI $16.02
- Resistance Level
- OABI $1.42
- LGI $16.29
- Average True Range (ATR)
- OABI 0.08
- LGI 0.18
- MACD
- OABI 0.03
- LGI -0.01
- Stochastic Oscillator
- OABI 39.02
- LGI 59.57
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About LGI Lazard Global Total Return and Income Fund
Lazard Global Total Return & Inc Fd Inc is a United States-based diversified, closed-end management investment company. Its investment objective is total return consisting of capital appreciation and income. The fund's portfolio of investments consists of different sector investments such as consumer staples, financials, consumer discretionary, healthcare, materials, sovereign debt and others.